Company / Profit Margin
Serina Therapeutics, Inc. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-14755.4%
FY2025
5-year range
-30770.6% / 167.1%
FY2021-FY2025
Trend
-8929.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -8930% YoY in FY2025, a notable deviation from the 6-year average annual change of -1671%.
Based on SEC 10-K filings.
-14755.4% in FY2025 with a 5-year CAGR of -14052.0%.
Declined from 167.1% to -14755.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +16015.2pp
- 5-Year Change
- -14052.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 8929.7% year-over-year.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14755.4% | -8929.7% |
| FY2024 | 167.1% | +0.0% |
| FY2023 | 167.1% | +100.5% |
| FY2022 | -30770.6% | -410.8% |
| FY2021 | -6024.3% | -756.5% |
| FY2020 | -703.4% | -30.9% |
| FY2018 | -537.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026